| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |